4.5 Article

Investigating the ibrutinib resistance mechanism of L528W mutation on Bruton's tyrosine kinase via molecular dynamics simulations

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Managing Waldenstrom's macroglobulinemia with BTK inhibitors

Christian Buske et al.

Summary: Bruton's tyrosine kinase (BTK) inhibition is a standard treatment option for patients with relapsed/refractory Waldenstrom's macroglobulinemia (WM). Although the first approved BTK inhibitor has limitations and is associated with cardiovascular side effects, the development of next-generation inhibitors and ongoing clinical trials show promising efficacy and safety, offering potential therapeutic options.

LEUKEMIA (2023)

Article Chemistry, Medicinal

Medicinal Chemistry Strategies for the Development of Bruton's Tyrosine Kinase Inhibitors against Resistance

Shan-Liang Sun et al.

Summary: This Perspective article focuses on medicinal chemistry strategies for developing small-molecule BTK inhibitors against resistance. It discusses the structure-based design of BTK inhibitors targeting point mutations and other strategies to overcome resistance, as well as comparative analysis of multi-inhibitions of BTK. The article also briefly addresses allosteric targeting of BTK and the use of PROTAC as potential strategies for finding novel BTK ligands.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Biotechnology & Applied Microbiology

Kinase inhibition in autoimmunity and inflammation

Ali A. Zarrin et al.

Summary: There are still unmet medical needs in the treatment of autoimmune and inflammatory diseases, despite recent advances in the field. Inhibitors targeting the activity of kinases that regulate production of inflammatory mediators have shown promising progress in drug development.

NATURE REVIEWS DRUG DISCOVERY (2021)

Article Hematology

Screening and monitoring of the BTKC481S mutation in a real-world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

Csaba Bodor et al.

Summary: The study found that the BTKC481S mutation is common in CLL patients and is associated with disease progression, appearing months before clinical relapse symptoms. Subsequent Bcl-2 inhibition therapy in patients with BTKC481S and progressing on ibrutinib treatment resulted in clinical and molecular remission.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Review Biochemistry & Molecular Biology

Bruton's Tyrosine Kinase Targeting in Multiple Myeloma

Max Von Suskil et al.

Summary: Multiple myeloma remains an incurable disease despite advancements in treatment, leading to aggressive relapses in patients. The cytosolic kinase BTK plays a crucial role in the survival of malignant clones and multiple myeloma stem cells, making it a promising therapeutic target. Inhibition of the BTK pathway may disrupt interactions between malignant clones and the bone marrow microenvironment in MM patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Biochemistry & Molecular Biology

Recent Advances in BTK Inhibitors for the Treatment of Inflammatory and Autoimmune Diseases

Datong Zhang et al.

Summary: BTK plays a crucial role in immunity, and its inhibition holds promise for treating inflammatory and autoimmune diseases; reversible inhibitors have not made significant breakthroughs, while covalent irreversible inhibitors have progressed more rapidly; many candidates are in clinical trials, with tolebrutinib and evobrutinib undergoing phase 3 evaluation.

MOLECULES (2021)

Review Oncology

Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advances

Tingyu Wen et al.

Summary: BTK inhibitor ibrutinib has revolutionized the management of B-cell malignancies by creating a chemotherapy-free era, with sales exceeding 230 billion dollars in just 6 years and becoming one of the top five best-selling medicines globally. Numerous clinical trials of BTK inhibitors were initiated in the past decade, with around 73 trials intensively announced or updated in the most recent 3 years.

LEUKEMIA (2021)

Review Biochemistry & Molecular Biology

Visualizing Protein Folding and Unfolding

Jennifer Ferina et al.

JOURNAL OF MOLECULAR BIOLOGY (2019)

Article Biochemistry & Molecular Biology

Argo: a data analysis program for quantum chemical calculations

Emmanouil C. Semidalas et al.

JOURNAL OF MOLECULAR MODELING (2019)

Article Pharmacology & Pharmacy

A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant BtkC481S mutation in B-cell malignancies

Fu Gui et al.

BRITISH JOURNAL OF PHARMACOLOGY (2019)

Article Computer Science, Artificial Intelligence

Compositionally-warped Gaussian processes

Gonzalo Rios et al.

NEURAL NETWORKS (2019)

Article Biochemistry & Molecular Biology

The SWISS-MODEL Repository-new features and functionality

Stefan Bienert et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Biochemistry & Molecular Biology

Battling Btk Mutants With Noncovalent Inhibitors That Overcome Cys481 and Thr474 Mutations

Adam R. Johnson et al.

ACS CHEMICAL BIOLOGY (2016)

Article Biochemical Research Methods

Protein stability: a crystallographer's perspective

Marc C. Deller et al.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2016)

Review Biochemistry & Molecular Biology

Protein Folding and Mechanisms of Proteostasis

Jose Fernando Diaz-Villanueva et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Article Biochemistry & Molecular Biology

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

Wyndham H. Wilson et al.

NATURE MEDICINE (2015)

Article Oncology

Ibrutinib: a first in class covalent inhibitor of Bruton's tyrosine kinase

Matthew S. Davids et al.

FUTURE ONCOLOGY (2014)

Article Biochemistry & Molecular Biology

DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach

Douglas E. V. Pires et al.

NUCLEIC ACIDS RESEARCH (2014)

Article Biochemistry & Molecular Biology

Contribution of hydrogen bonds to protein stability

C. Nick Pace et al.

PROTEIN SCIENCE (2014)

Article Medicine, General & Internal

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael L. Wang et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Article Biochemistry & Molecular Biology

Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanism

Xiaozhen Yu et al.

JOURNAL OF MOLECULAR MODELING (2012)

Article Biochemistry & Molecular Biology

Insights into the conformational flexibility of Bruton's tyrosine kinase from multiple ligand complex structures

Andreas Kuglstatter et al.

PROTEIN SCIENCE (2011)

Article Biochemistry & Molecular Biology

Radius of gyration as an indicator of protein structure compactness

M. Yu. Lobanov et al.

MOLECULAR BIOLOGY (2008)

Article Biochemistry & Molecular Biology

Prediction of protein stability changes for single-site mutations using support vector machines

JL Cheng et al.

PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2006)

Review Chemistry, Multidisciplinary

Mechanisms of protein assembly: Lessons from minimalist models

Y Levy et al.

ACCOUNTS OF CHEMICAL RESEARCH (2006)

Article Biochemistry & Molecular Biology

I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure

E Capriotti et al.

NUCLEIC ACIDS RESEARCH (2005)

Article Chemistry, Multidisciplinary

UCSF chimera - A visualization system for exploratory research and analysis

EF Pettersen et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)